EBIM
CBST

Eagle Boston Investment Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Eagle Boston Investment Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,506
Closed -$1.26M – 184
2014
Q4 		$1.26M Sell
12,506
-554,662
-98% -$43.1M 0.08% 128
2014
Q3 		$37.6M Sell
567,168
-11,039
-2% -$725K 2.08% 4
2014
Q2 		$40.4M Sell
578,207
-18,394
-3% -$1.25M 2.01% 4
2014
Q1 		$43.6M Sell
596,601
-101,775
-15% -$7.59M 2.15% 3
2013
Q4 		$48.1M Buy
698,376
+136,966
+24% +$8.87M 2.33% 2
2013
Q3 		$36.4M Sell
561,410
-11,352
-2% -$686K 2.21% 5
2013
Q2 		$27.7M Buy
+572,762
New +$28.1M 1.84% 5

Eagle Boston Investment Management's CBST Position: Q1 2015 in Review

Eagle Boston Investment Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 12,506 shares — an estimated $1.26M sold.

Eagle Boston Investment Management first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $48.1M in Q4 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Eagle Boston Investment Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Eagle Boston Investment Management sold 12,506 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.26M.
  • Eagle Boston Investment Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Eagle Boston Investment Management's CUBIST PHARMACEUTICALS INC position peaked at $48.1M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Eagle Boston Investment Management's 13F filing for Q1 2015, filed 22 Apr 2015.